Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 38638079)

  • 1. Immunotherapy in Stage III-IV Colon Cancer: A Propensity Score-Matched Analysis of the National Cancer Database.
    Horesh N; Emile SH; Garoufalia Z; Gefen R; Zhou P; Nagarajan A; Wexner SD
    J Immunother; 2024 Apr; ():. PubMed ID: 38638079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunotherapy in rectal cancer patients-a propensity score matched analysis of the National Cancer Database.
    Horesh N; Emile SH; Freund MR; Garoufalia Z; Gefen R; Nagarajan A; Wexner SD
    Int J Colorectal Dis; 2023 Dec; 39(1):8. PubMed ID: 38133666
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Propensity-Score Matched Analysis of Survival Outcomes of Adjuvant Therapy in Stage II-III Signet-Ring Cell Carcinoma of the Colon.
    Emile SH; Horesh N; Garoufalia Z; Gefen R; Strassmann V; Wexner SD
    Clin Colorectal Cancer; 2024 Mar; 23(1):35-45. PubMed ID: 37980215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Survival benefit from immunocheckpoint inhibitors in stage IV non-small cell lung cancer patients with brain metastases: A National Cancer Database propensity-matched analysis.
    Takamori S; Komiya T; Powell E
    Cancer Med; 2021 Feb; 10(3):923-932. PubMed ID: 33340271
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minimally invasive surgery for stage III colon adenocarcinoma is associated with less delay to initiation of adjuvant systemic therapy and improved survival.
    Lee L; Wong-Chong N; Kelly JJ; Nassif GJ; Albert MR; Monson JRT
    Surg Endosc; 2019 Feb; 33(2):460-470. PubMed ID: 29967992
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is There a Role for Neoadjuvant Systemic Therapy for cT4bM0 Colon Cancer? A Propensity Score-Matched Analysis of the National Cancer Database.
    Kamel MK; Shchatsko A; Keane CA; Serpa E; Al-Qudah G; Rahouma M; Nituica C; Blebea J; Marar O
    Dis Colon Rectum; 2023 Nov; 66(11):1435-1448. PubMed ID: 36876973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of immunotherapy use in patients with stage IV pancreatic carcinoma.
    Guddati AK; Komiya T; Patel SJ; Sharma N; Powell E
    J Gastrointest Oncol; 2020 Aug; 11(4):654-662. PubMed ID: 32953149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of immunotherapy time-of-day infusion on overall survival among patients with advanced melanoma in the USA (MEMOIR): a propensity score-matched analysis of a single-centre, longitudinal study.
    Qian DC; Kleber T; Brammer B; Xu KM; Switchenko JM; Janopaul-Naylor JR; Zhong J; Yushak ML; Harvey RD; Paulos CM; Lawson DH; Khan MK; Kudchadkar RR; Buchwald ZS
    Lancet Oncol; 2021 Dec; 22(12):1777-1786. PubMed ID: 34780711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary tumor location and survival in colorectal cancer: A retrospective cohort study.
    Aggarwal H; Sheffield KM; Li L; Lenis D; Sorg R; Barzi A; Miksad R
    World J Gastrointest Oncol; 2020 Apr; 12(4):405-423. PubMed ID: 32368319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in Health Care Costs, Survival, and Time Toxicity in the Era of Immunotherapy and Targeted Systemic Therapy for Melanoma.
    Bateni SB; Nguyen P; Eskander A; Seung SJ; Mittmann N; Jalink M; Gupta A; Chan KKW; Look Hong NJ; Hanna TP
    JAMA Dermatol; 2023 Nov; 159(11):1195-1204. PubMed ID: 37672282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lower survival after right-sided versus left-sided colon cancers: Is an extended lymphadenectomy the answer?
    Lee L; Erkan A; Alhassan N; Kelly JJ; Nassif GJ; Albert MR; Rt Monson J
    Surg Oncol; 2018 Sep; 27(3):449-455. PubMed ID: 30217301
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Propensity-score matched analysis of the pathologic outcomes and survival benefits of neoadjuvant therapy in stage II-III anal adenocarcinoma.
    Emile SH; Horesh N; Garoufalia Z; Gefen R; Zhou P; Wexner SD
    J Surg Oncol; 2023 Sep; 128(4):585-594. PubMed ID: 37183543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Better survival in right-sided versus left-sided stage I - III colon cancer patients.
    Warschkow R; Sulz MC; Marti L; Tarantino I; Schmied BM; Cerny T; Güller U
    BMC Cancer; 2016 Jul; 16():554. PubMed ID: 27464835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Survival outcomes for right-versus left-sided colon cancer and rectal cancer in England: A propensity-score matched population-based cohort study.
    Hodges N; Mackenzie H; D'Souza N; Brown G; Miskovic D
    Eur J Surg Oncol; 2022 Apr; 48(4):841-849. PubMed ID: 34688513
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of Liver Metastasis on First-Line Immunotherapy in Stage IV Non-Small Cell Lung Cancer.
    Komiya T; Takamori S; Shimokawa M
    World J Oncol; 2023 Aug; 14(4):234-245. PubMed ID: 37560341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neutrophil-to-lymphocyte ratio is a prognostic factor for colon cancer: a propensity score analysis.
    Mazaki J; Katsumata K; Kasahara K; Tago T; Wada T; Kuwabara H; Enomoto M; Ishizaki T; Nagakawa Y; Tsuchida A
    BMC Cancer; 2020 Sep; 20(1):922. PubMed ID: 32977767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Duration of chemotherapy prior to chemoradiation affects survival outcomes for resected stage I-II or unresected stage III pancreatic cancer.
    Ma SJ; Iovoli AJ; Hermann GM; Prezzano KM; Singh AK
    Cancer Med; 2019 Aug; 8(9):4110-4123. PubMed ID: 31183965
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunotherapy After Chemotherapy and Radiation for Clinical Stage III Lung Cancer.
    Pichert MD; Canavan ME; Maduka RC; Li AX; Ermer T; Zhan PL; Kaminski M; Udelsman BV; Blasberg JD; Park HS; Goldberg SB; Boffa DJ
    JAMA Netw Open; 2022 Aug; 5(8):e2224478. PubMed ID: 35925606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Propensity Score Matching Analysis of the Effect of Payer Status on the Survival of Colon Cancer Patients.
    Shi L; Suh W; Kavanaugh MM; Mills G; Thayer S; Shi R
    Cureus; 2021 Jun; 13(6):e15748. PubMed ID: 34285854
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of 627 patients with right- and left-sided colon cancer in China: Differences in clinicopathology, recurrence, and survival.
    Qin Q; Yang L; Sun YK; Ying JM; Song Y; Zhang W; Wang JW; Zhou AP
    Chronic Dis Transl Med; 2017 Mar; 3(1):51-59. PubMed ID: 29063056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.